A biotech working on a new approach to IVF raises $33M in fresh funding
BioPharma
Source: biopharmadive.com
📰 March Venture News
March Venture News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from March Venture. Real-time updates on events, politics, business and more.
Bit.bio Announced as Inaugural Partner of Ginkgo Bioworks' New Technology Network -February 28, 2024 at 07:13 am EST
The Ginkgo Technology Network brings together over 25 diverse partners across an array of capabilities including AI, genetic medicines, biologics, and manufacturing. As a Ginkgo Technology...
United Kingdom Jason Kelly Mark Kotter Instagram Ginkgobioworks Ginkgo Technology Network Verition Fund
Source: marketscreener.com
Lose Fat, Not Muscle: Next Test for Lilly's Zepbound Pairs It With BioAge Drug
In preclinical testing, combining BioAge Labs’ experimental drug with Eli Lilly weight drug Zepbound led to greater weight loss compared with Zepbound alone. Now the company plans to run a Phase 2 study to see if it can replicate those results in humans.
Source: medcitynews.com
bit.bio further expands ioCells™️ range with early access launch of ioMotor Neurons™️ for research a
A reliable supply of consistent and physiologically relevant motor neurons is fundamental to the study and screening of potential treatments for motor neuron diseasesioMotor Neurons also offer an alternative to animals for neurotoxicity testing in the development of therapeutic products and consumer cosmetics proced...
Source: pharmiweb.com
Scientists at King's College London and bit.bio Collaborate to Develop Multi-Cell Models of the Human Brain With Optimised Open-Source Protocols for Use by Any Researcher
CAMBRIDGE, England--(BUSINESS WIRE)--Nov 24, 2023--
Source: bdtonline.com
Avalyn's New Twist on Older Lung Disease Drugs Attracts $175M for Clinical Trials
Avalyn Pharma aims to improve treatment of Idiopathic pulmonary fibrosis with inhalable versions of two older oral drugs and it’s now headed for mid-stage testing backed by a Series C financing. Other recent biotech industry financings raised money for research in cancer, immunology, and rare genetic diseases.
Source: medcitynews.com
Tracking 2023's Largest IPOs: Instacart, Arm, Klaviyo and More
The U.S. IPO market is slowly waking up from an 18-month pause. Here are the largest listings you need to know.
Source: observer.com
Tracking 2023's Largest IPOs: Instacart, Arm, Klaviyo and More (Updated Sept.)
The U.S. IPO market is slowly waking up from an 18-month pause. Here are the largest listings you need to know.
Source: yahoo.com